Are you a professional? Activate your profile

Are you already registered? Access Forgot your password?

Financial advisors
Calculation tools
- Calculates the risk and return of a securities portfolio
- Calculate your supplementary pension
News from the UK Stock Exchange

Funds / ETFs / Stock Ranking
Learn about finance
- Financial glossary
- Learning to invest
  The most important concepts of finance
Study Office
- Asset allocation
- Finance app ranking
About us

PaxMedica Inc. - news published 124 - readings 1.019

BACK

PaxMedica Inc.

Management Change/Compensation Form 8 K

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On July 16, 2024, Dr. David Hough, chief medical officer of PaxMedica, Inc., a Delaware corporation (the "Company"), provided notice of his resignation as an executive officer of the Company. Dr. Hough's decision ...

19.07.2024

PaxMedica Inc.

Failure to Satisfy Listing Rule Form 8 K

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard. On June 10, 2024, The Nasdaq Stock Market LLC ("Nasdaq") notified PaxMedica, Inc. (the "Company") that the Nasdaq staff has determined that the Company no longer complies with the minimum $2,500,000 in stockholders' equity for continued listing. The Nasdaq staff reache ...

14.06.2024

PaxMedica Inc.

Submission of Matters to a Vote of Security Holders - Form 8-K

Item 5.07 Submission of Matters to a Vote of Security Holders The Annual Meeting of Stockholders of PaxMedica, Inc. (the " Company ") was held on May 23, 2024 (the " Annual Meeting "). At the Annual Meeting, there were present, in person virtually or by proxy, holders of 3,483,383 shares of common stock, or approximately 46.6% of the total outstanding share ...

28.05.2024

PaxMedica Inc.

PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101 - Form 8-K

PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101 TARRYTOWN, NY / ACCESSWIRE / May 15, 2024 / PaxMedica, Inc. (the "Company" or "PaxMedica")(OTC:PXMD) , a biopharmaceutical company dedicated to advancing treatments for neurological disorders, today announced it has timely filed a formal notice of appeal with the ...

15.05.2024

PaxMedica Inc.

Quarterly Report for Quarter Ending March 31, 2024 (Form 10-Q)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition pe ...

13.05.2024

PaxMedica Inc.

Failure to Satisfy Listing Rule - Form 8-K

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard. On April 30, 2024, The Nasdaq Stock Market LLC ("Nasdaq") notified PaxMedica, Inc. (the "Company") that the Nasdaq Hearings Panel (the "Panel") has determined to delist the Company's common stock and that trading of the Company's securities will be suspended ...

02.05.2024

PaxMedica Inc.

PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101 - Form 8-K

PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101 TARRYTOWN, NY / ACCESSWIRE / April 23, 2024 /, PaxMedica Inc. (Nasdaq: PXMD) (the "Company"), a leading biopharmaceutical company dedicated to advancing treatments for neurological disorders, expects to take immediate action in response to an urgent request for I ...

23.04.2024

PaxMedica Inc.

PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness - Form 8-K

PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness · Emergent shortages of the drug used to treat the most severe form of African sleeping sickness creates immediate need for direct access to the global drug market for affected nations · As previously reported , PaxMedica recently executed final regist ...

16.04.2024

PaxMedica Inc.

Proxy Statement - Form DEF 14A

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant To Section 14(A) Of The Securities Exchange Act Of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of ...

15.04.2024

PaxMedica Inc.

Annual Report - Form ARS

The text version of this document is not available. You can access the original document here . Attachments Original Link Permalink Disclaimer PaxMedica Inc. published this content on 15 April 2024 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 15 April 2024 20:41:49 UTC .

15.04.2024

PaxMedica Inc.

PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission - Form 8-K

PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission TARRYTOWN, NY / ACCESSWIRE / April 11, 2024 / PaxMedica , Inc. (NASDAQ: PXMD ), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announced the completed execution of its three pivotal registration/validation batches of PAX- ...

11.04.2024

PaxMedica Inc.

Preliminary Proxy Statement - Form PRE 14A

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant To Section 14(A) Of The Securities Exchange Act Of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of ...

03.04.2024

PaxMedica Inc.

Certificate of Incorporation/Bylaws - Form 8-K

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On March 21, 2024, the Board of Directors of PaxMedica, Inc. amended Section 1.6 of Article I of PaxMedica, Inc.'s Amended and Restated Bylaws to reduce the quorum requirement for any meeting of stockholders to 33.4%. A copy of the First Amendment to the Amended and Restated Bylaws is attached ...

22.03.2024

PaxMedica Inc.

Statement of Changes in Beneficial Ownership - Form 4

Ownership Submission FORM 4 Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b). UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investmen ...

14.03.2024

PaxMedica Inc.

Statement of Changes in Beneficial Ownership - Form 4

14.03.2024

PaxMedica Inc. - news published 124 - readings 1.019

PaxMedica Inc.

Management Change/Compensation Form 8 K

PaxMedica Inc.

Failure to Satisfy Listing Rule Form 8 K

PaxMedica Inc.

Submission of Matters to a Vote of Security Holders - Form 8-K

PaxMedica Inc.

PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101 - Form 8-K

PaxMedica Inc.

Quarterly Report for Quarter Ending March 31, 2024 (Form 10-Q)

PaxMedica Inc.

Failure to Satisfy Listing Rule - Form 8-K

PaxMedica Inc.

PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101 - Form 8-K

PaxMedica Inc.

PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness - Form 8-K

PaxMedica Inc.

Proxy Statement - Form DEF 14A

PaxMedica Inc.

Annual Report - Form ARS

PaxMedica Inc.

PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission - Form 8-K

PaxMedica Inc.

Preliminary Proxy Statement - Form PRE 14A

PaxMedica Inc.

Certificate of Incorporation/Bylaws - Form 8-K

PaxMedica Inc.

Statement of Changes in Beneficial Ownership - Form 4

PaxMedica Inc.

Statement of Changes in Beneficial Ownership - Form 4

You have reached the maximum number of requests. You can no longer send.

Become Member

€2,99per month

Become Member

€2,99per month

You have reached the maximum
number of requests.
You can no longer send.

Become
Member

Become
Member